Patients receiving treatment for cancer at Cairns Hospital in Australia have shown a strong willingness to receive vaccinations for influenza and pneumococcal diseases, according to a recent survey published in the Journal of Oncology Pharmacy Practice. Despite this readiness, vaccination rates remain low, highlighting a significant opportunity for pharmacists to enhance vaccination services in oncology settings.
The study, which surveyed 107 patients in the outpatient oncology department, revealed that while 55.1% of respondents had received an influenza vaccine in the last year, only 22.4% reported having received a pneumococcal vaccine in the past five years. These figures suggest that even though patients are confident in pharmacist-led vaccination, many are not utilizing available services.
Understanding the Risks for Cancer Patients
Patients with cancer face unique health challenges, particularly due to the immunosuppressive effects of treatments. This vulnerability increases their risk of serious respiratory infections, including influenza and pneumonia. Research indicates that cancer patients are significantly more likely to experience influenza or pneumonia-related fatalities compared to the general population. For instance, individuals with immune deficiencies related to cancer have rates of invasive pneumococcal disease (IPD) reaching 503 cases per 100,000, contrasted with 8.8 cases per 100,000 in the broader community.
Given these alarming statistics, effective vaccination programs are essential. Pharmacists, especially those working in oncology, have the potential to play a pivotal role in encouraging patients to receive vaccinations. They can not only identify eligible patients but also serve as educators, improving awareness and facilitating access to vaccines.
Patient Perspectives on Pharmacist-Delivered Vaccination
The survey conducted at Cairns Hospital included 32 questions aimed at assessing patients’ beliefs and perceptions regarding vaccinations. Findings showed a generally positive attitude towards vaccination, with 69.2% of respondents expressing a willingness to be vaccinated with minimal concerns. Interestingly, while only 5.5% of patients had received vaccinations at a hospital or public clinic, an overwhelming 80.4% indicated a preference for receiving vaccinations at a cancer center.
Despite the willingness to receive vaccinations, only 55.1% of patients were open to recommendations from pharmacists regarding vaccinations. Nevertheless, the survey revealed that 86% of participants would be willing to receive at least one vaccine from a pharmacist, and 61.7%